摘要
目的:研究金属硫蛋白(MT)和肿瘤增殖抗原(Ki-67)在卵巢上皮性肿瘤组织中的表达及相关性和临床意义。方法:采用免疫组化SP法及半定量分析法,检测105例卵巢上皮性肿瘤病理标本中的MT及Ki-67蛋白表达。结果:MT在卵巢癌及正常组织中表达有差异(P<0.01),Ki-67在不同组织学类型卵巢肿瘤间表达无明显差异(P>0.05);MT与Ki-67的表达强度恶性肿瘤高于正常、良性、交界性肿瘤(P<0.05),临床Ⅲ、Ⅳ期,病理2、3级的恶性肿瘤高于临床Ⅰ、Ⅱ期,病理1级者(P<0.01);MT与Ki-67的表达强度在恶性上皮性卵巢肿瘤中有显著相关性(P<0.05)。结论:组织中MT、Ki-67的表达强度与卵巢肿瘤的性质有关,MT和Ki-67可能作为卵巢肿瘤的预后预测参考指标。
Objective:To study the expressions of metallothionein and tumor proliferating antigen(Ki-67) in epithelial ovarian carcinoma tissues,analyze their correlation and clinical significances.Methods:Immunohistochemical SP method and semi-quantitative analysis were used to detect the expressions of metallothionein and Ki-67 protein in pathological samples of epithelial ovarian carcinoma.Results:There was significant difference in expression level of metallothionein between ovarian cancer and normal ovary(P〈0.01),there was no significant difference in expression level of Ki-67 protein among ovarian carcinoma of different histological types(P〉0.05);the expression levels of metallothionein and Ki-67 protein in malignant tumors were significantly higher than those in normal ovary,benign and borderline tumors(P〈0.05);the expression levels of metallothionein and Ki-67 protein in malignant tumors of clinical stage Ⅲ,Ⅳ,pathological grade 2,3 were significantly higher than those in malignant tumors of clinical stage Ⅰ,Ⅱ,pathological grade 1;in malignant epithelial ovarian tumors,there was a significant correlation between metallothionein expression and Ki-67 protein expression(P〈0.05).Conclusion:The expression levels of metallothionein and Ki-67 protein are related to tumor type,metallothionein and Ki-67 protein may be used as indications of clinical prognosis of ovarian tumors
出处
《中国妇幼保健》
CAS
北大核心
2011年第6期907-908,共2页
Maternal and Child Health Care of China
关键词
卵巢癌
金属硫蛋白
肿瘤增殖抗原
Ovarian cancer
Metallothionein
Tumor proliferating antigen